Ahead of a key House committee meeting, bipartisan congressional lawmakers are promoting their amendment to a spending bill that would encourage research into the therapeutic potential of certain psychedelics.
The amendment from Reps. Lou Correa (D-CA) and Jack Bergman (R-MI) is being proposed as part of appropriations legislation covering Military Construction, Veterans Affairs and Related Agencies (MilCon/VA). The House Rules Committee is set to meet on Tuesday to determine whether it will be made in order for floor consideration.
“Our nation’s veterans continue to needlessly suffer tragic rates of suicide and opioid overdose deaths, and it’s crucial that the VA do all it can to ensure that those who would benefit most from these potentially lifesaving therapies can get access to them—as soon as possible,” Correa said in a press release on Monday. “Congress has the power to fix this, and with this amendment, we’ll push the VA to research the impact of breakthrough therapies, like psychedelics, that are already saving the lives of veterans in this country.”
The lawmakers’ amendment is meant to encourage VA to carry out “large-scale studies” into drugs like psilocybin and MDMA that have been designated as “breakthrough therapies” by the Food and Drug Administration
Read full article on Marijuana Moment
